Literature DB >> 21148129

Retraction. Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer. J Clin Oncol 25:4350–7, 2007.

.   

Abstract

Entities:  

Year:  2010        PMID： 21148129     DOI： 10.1200/JCO.2010.33.7311

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Practical ethics: establishing a pathway to benefit for complex pharmacogenomic tests.

Authors:  S B Haga; W Burke
Journal:  Clin Pharmacol Ther       Date:  2011-07       Impact factor: 6.875

2.  Microarray-based oncogenic pathway profiling in advanced serous papillary ovarian carcinoma.

Authors:  Xuan Bich Trinh; Wiebren A A Tjalma; Luc Y Dirix; Peter B Vermeulen; Dieter J Peeters; Dimcho Bachvarov; Marie Plante; Els M Berns; Jozien Helleman; Steven J Van Laere; Peter A van Dam
Journal:  PLoS One       Date:  2011-07-25       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.